National News Health

India’s first COVID-19 vaccine ‘Covaxin’ gets DCGI nod for human trials

July 1, 2020, 2:43 AM

Sneha Shah | Hyderabad

Bharat Biotech’s drug COVAXIN, the first potential COVID-19 vaccine of India, has been granted permission to initiate Phase I and II human clinical trials from The Drug Controller General of India (DCGI). The clinical trials by the Hyderabad-based company will start across the country in July 2020.

The company has claimed that it is India’s first candidate for COVID-19 vaccine, developed in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).

A statement issued by the company read: The SARS-CoV-2 strain was isolated in NIV (Pune) and transferred to Bharat Biotech. The indigenous inactivated vaccine was developed and manufactured in Bharat Biotech’s BSL-3 (Bio-Safety Level 3) high containment facility located in Genome Valley, Hyderabad, India.

Also read : Delhi to have Plasma bank, CM Arvind Kejriwal asks COVID-19 survivors to donate

Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech said that the proactive support and guidance from The Central Drugs Standard Control Organisation (CDScO) has enabled approvals to this project. Our R&D and manufacturing teams worked tirelessly to deploy our proprietary technologies towards this platform, she added.

Joint Managing Director of the company, Suchitra Ella said that their ongoing research and expertise in forecasting epidemics enabled then to successfully manufacture a vaccine for the H1N1 pandemic. They are continuing their focus on creating the only BSL-3 containment facilities for manufacturing and testing in the country.

Health

Union Minister Dr Bhagwat Karad unveils Dr Kavita Chandak’s book ‘Healing women with Homeopathy’

Published

3 years ago

May 19, 2022

Nation Next Newsroom | Aurangabad

Dr Kavita Chandak at National Conference of Homeopathy held in Aurangabad

Minister of State for Finance Dr Bhagwat Karad recently unveiled Dr Kavita Chandak’s book ‘Healing women with Homeopathy’ at the recently held National Conference of Homeopathy (HAMI 2022) in Aurangabad. Prominently present during the conference were renowned homeopath Dr Arun Bhasme and 3,000 other doctors.

In her book, Dr Chandak, who hails from Nagpur, has covered the most important and widespread gynecological disorders such as menarche, over dysmenorrhea to menopause; reflects issues from which women suffer frequently like sterility, polycystic ovarian syndrome, breast issues, pregnancy-related conditions like constipation, morning sickness, heartburn, uterine prolapse, varicose veins, hemorrhoids, and urinary problems, to mention a few.

Dr Chandak has also given a thorough explanation on topics like cancer of the breast, uterus and cervix, which are the most prevalent types of cancers in women. Her book contains a study of several homeopathic remedies with special emphasis on gynecology through the chapters like the core of a few important female remedies and the homeopathic gynecological kit. The book also gives a glimpse of rare and lesser-known remedies.

It is worth noting that Dr Chandak holds two golden book world records for treating kidney disorders and a case of mucormycosis. She is also the recipient of ‘The Excellence in Homeopathy award 2022’ given by Hpathy.com to 66 renowned homeopaths throughout the world. Over the years, Dr Chandak has organized more than 800 free medicine distribution camps. She provides her services through her web clinic in 20+ countries. Her area of specialization is behavioral psychiatric disorders like autism and ADHD.